Filana Therapeutics (FLNA) Stock Analysis: AI Score & Alternative Data
Demand signals are heating up for Filana Therapeutics
Is Filana Therapeutics a buy right now? The alternative data says hold. This FLNA stock analysis is built on the 25+ alternative data signals AltIndex tracks on Filana Therapeutics every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 55/100: a Hold. The stock trades at $0.87 with a $45M market cap.
The data leans positive over the past 90 days — sentiment up 31.8% to 87/100 — but the move hasn’t been broad enough to lift FLNA into buy territory yet.
FLNA’s broader alt-data profile also covers headcount (14 employees, according to LinkedIn), and web traffic (2K monthly visits). Every signal links to its own page with full history, the FLNA technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on FLNA is just below.
Filana Therapeutics AI Stock Analysis
Filana Therapeutics is a biopharmaceutical company specializing in innovative therapies for rare diseases. The company focuses on developing and commercializing treatments that target unmet medical needs, providing breakthrough solutions for patients worldwide.
Analysis generated September 30, 2026.
Recent Filana Therapeutics Stock Alerts
|
Filana Therapeutics | October 5 Price is down by -6.2% in the last 24h. |
|
Filana Therapeutics | October 3 Insider Alert: Barry Richard is buying shares |
|
Filana Therapeutics | October 2 Price is up by 6.2% in the last 24h. |
|
Filana Therapeutics | October 1 Price is up by 12.9% in the last 24h. |
Filana Therapeutics Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 2K | N/A | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 14 | N/A | |
| Wikipedia Views | 19 | 13.6% | |
| Sentiment | 87 | 31.8% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 4 | N/A | |
| Stocktwits Mentions | 88 | 1,366.7% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 51K | N/A |
About Filana Therapeutics (FLNA)
FuelNation Inc., a development stage company, engages in the purchase, transportation, storage, and resale of petroleum products. The company is headquartered in West Palm Beach, Florida.
| Price | $0.87 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $45M |
| Year Range | $1 – $5 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Filana Therapeutics News
View more → |
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?August 12 - PRNewswire |
Newcleo begins trading on NasdaqSeptember 22 - Thefly.com |
|
See Filana Therapeutics’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for FLNA, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEFilana Therapeutics Earnings & Financial Performance
View all earnings →Filana Therapeutics Insider Trading Activity
View all →| Barry Richard filed to sell 1,337,964 shares at $0.0. Sep 30 '26 |
| Barry Richard filed to sell 1,237,964 shares at $0.0. Sep 29 '26 |
Filana Therapeutics Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Filana Therapeutics
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Werewolf TherapeuticsHOWL |
$0.93 0.2% | $45M | 41 |
 |
LeonaBioLONA |
$5.58 15.8% | $45M | 50 |
 |
Tevogen Bio HoldingsTVGN |
$6.60 5.4% | $45M | 42 |
 |
Impact BioMedicalIBO |
$4.84 9.0% | $45M | 44 |
 |
VeruVERU |
$2.55 1.6% | $43M | 46 |
Explore Filana Therapeutics Data
Frequently Asked Questions: Filana Therapeutics (FLNA)
Filana Therapeutics has an AltIndex AI Score of 55/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
55/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Filana Therapeutics (FLNA) stock is $0.87 with a market cap of $45M.
As of today, Filana Therapeutics’s PE (Price to Earnings) ratio is —.
View the latest Filana Therapeutics insider transactions to see recent buying and selling activity by company executives and directors.
Check the Filana Therapeutics congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The FLNA stock price chart above shows Filana Therapeutics’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Filana Therapeutics technical analysis for RSI, moving averages, and more.
See the stocks similar to Filana Therapeutics section on this page for companies in the same industry ranked by market cap and AI Score.
